Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)-Reference-Cited by-同舟云学术

Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)

Published:2009-05 Issue:10 Volume:103 Page:1359-1363
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Dasgupta Arijit,Steinhubl Steven R.,Bhatt Deepak L.,Berger Peter B.,Shao Mingyuan,Mak Koon-Hou,Fox Keith A.A.,Montalescot Gilles,Weber Michael A.,Haffner Steven M.,Dimas Alexios P.,Steg P. Gabriel,Topol Eric J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE);Lancet,1996

2. Changes in platelet membrane glycoproteins and platelet-leukocyte interaction during hemodialysis;Gawaz;Clin Invest,1994

3. The efficacy and safety of long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation Trial (CREDO) Trial;Best;Am Heart J,2008

4. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel;Keltai;Eur J Cardiovasc Prev Rehabil,2007

5. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events;Bhatt;N Engl J Med,2006

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD;JACC: Basic to Translational Science;2024-07

2. Modern strategies for the treatment of type 2 diabetes in patients with stable coronary artery disease. Old goals, new opportunities (literature review);Russian Journal of Cardiology;2024-01-15

3. Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients;Life;2023-06-29

4. Antithrombotic therapy in patients with diabetes mellitus;Bulletin of the Russian Military Medical Academy;2023-01-04

5. Type two diabetes mellitus and microvascular complications in patients with coronary artery disease: prevalence, prognosis and choice of antithrombotic therapy;South Russian Journal of Therapeutic Practice;2022-12-30